IL17A and neoplasm: For instance, Chung et al. recently demonstrated that interleukin-17 (IL-17) produced by T helper type 17 (TH17) cells promotes tumor resistance to the inhibition of VEGF by mediating immature myeloid-cell mobilization and recruitment into the tumor microenvironment [81].